Search Results - "Joshi, Anjali B."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Studies on the mechanism of aspartic acid cleavage and glutamine deamidation in the acidic degradation of glucagon by Joshi, Anjali B, Sawai, Monali, Kearney, William R, Kirsch, Lee E

    Published in Journal of pharmaceutical sciences (01-09-2005)
    “…In this study, the polypeptide hormone glucagon was used as a model to investigate the mechanisms of aspartic acid cleavage and glutaminyl deamidation in…”
    Get more information
    Journal Article
  2. 2

    The degradation pathways of glucagon in acidic solutions by Joshi, Anjali B, Rus, Elena, Kirsch, Lee E

    Published in International journal of pharmaceutics (10-08-2000)
    “…Objective: Glucagon is a 29 amino acid peptide hormone that exhibits degradation via both chemical and physical pathways. The objective of the studies reported…”
    Get full text
    Journal Article
  3. 3

    The estimation of glutaminyl deamidation and aspartyl cleavage rates in glucagon by Joshi, Anjali B., Kirsch, Lee E.

    Published in International journal of pharmaceutics (01-04-2004)
    “…The major hydrolytic degradation pathways of glucagon under acidic conditions are cleavage at Asp-9, Asp-15, and Asp-21, and deamidation at Gln-3, Gln-20,…”
    Get full text
    Journal Article
  4. 4

    The relative rates of glutamine and asparagine deamidation in glucagon fragment 22-29 under acidic conditions by Joshi, Anjali B, Kirsch, Lee E

    Published in Journal of pharmaceutical sciences (01-11-2002)
    “…Our objective was to compare the relative rates of asparaginyl and glutaminyl deamidation in fragment 22-29 of the polypeptide hormone glucagon in acidic…”
    Get more information
    Journal Article
  5. 5

    Preformulation Studies on the S-Isomer of Oxybutynin Hydrochloride, an Improved Chemical Entity (ICE™) by Luner, Paul E., Kirsch, Lee E., Majuru, Shingai, Oh, Euichaul, Joshi, Anjali B., Wurster, Dale Eric, Redmon, Martin P.

    Published in Drug development and industrial pharmacy (01-01-2001)
    “…(S)-Oxybutynin HCl (S-OXY) is a white crystalline solid powder with an acicular particle morphology. Differential scanning calorimetry (DSC) thermograms…”
    Get full text
    Journal Article